OmniAb (OABI) Other Non-Current Assets (2021 - 2026)

OmniAb's (OABI) quarterly Other Non-Current Assets came in at $560000.0 in Q1 2026, little changed year-on-year from $560000.0 in Q1 2025, and down 38.6% on a QoQ basis from $912000.0 in Q4 2025.

OmniAb (OABI) Other Non-Current Assets (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Other Non-Current Assets data on file, last reported at $560000.0 in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $560000.0 in Q1 2026; TTM through Mar 2026 was $560000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $912000.0, up 62.86% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $560000.0, down from $912000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for OABI reached as high as $3.3 million in Q2 2023 and fell as low as $449000.0 in Q4 2022.
  • Historically, Other Non-Current Assets has averaged $1.2 million across 5 years, with a median of $560000.0 in 2023.
  • Across the five-year window, Other Non-Current Assets slumped 83.26% in 2024 and surged 62.86% in 2025, its largest moves.
  • Year by year, Other Non-Current Assets stood at $449000.0 in 2022, then increased by 24.72% to $560000.0 in 2023, then changed by 0.0% to $560000.0 in 2024, then jumped by 62.86% to $912000.0 in 2025, then slumped by 38.6% to $560000.0 in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $560000.0 in Q1 2026, $912000.0 in Q4 2025, and $560000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 OmniAb 261.62 Mn 212.55 Mn 14.41 Mn 560,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 560,000.00
Dec 31, 2025 912,000.00
Sep 30, 2025 560,000.00
Jun 30, 2025 560,000.00
Mar 31, 2025 560,000.00
Dec 31, 2024 560,000.00
Sep 30, 2024 1.62 Mn
Jun 30, 2024 560,000.00
Mar 31, 2024 560,000.00
Dec 31, 2023 560,000.00
Sep 30, 2023 3.19 Mn
Jun 30, 2023 3.35 Mn
Mar 31, 2023 3.34 Mn
Dec 31, 2022 449,000.00
Dec 31, 2021 1.50 Mn